Drug Type Fc Fragment |
Synonyms |
Target |
Mechanism FcγR modulators(FcγR modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Nuvig Therapeutics, Inc.Startup |
Active Organization Nuvig Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myositis | Preclinical | US | Nuvig Therapeutics, Inc.Startup | 12 Feb 2024 |
Pemphigoid, Bullous | Preclinical | US | Nuvig Therapeutics, Inc.Startup | 12 Feb 2024 |